> Program > Scientific Program
 

Day 1, Apr 20(Thu.) Day 2, Apr 21 (Fri.) Day 3, Apr 22 (Sat.)

Plenary Lecture 1 : Past and Future Treatment of HER2-positive Breast Cancer
Date & Time Apr 20 (Thu.), 11:10-12:10 Venue Halla Hall
Moderators
Speakers
Can anti-HER2 Treatment for Advanced Breast Cancer Disease be Individualized in 2017?
Prof.Martine Piccart (Institut Jules Bordet, Belgium)



Satellite Symposium 1 : The Role of Faslodex in Advanced Breast Cancer Management Pursuing Long Term Treatment Strategy
Date & Time Apr 20 (Thu.), 12:10-13:10 Venue Halla Hall
Moderators
Prof.Dong-young Noh (Seoul National Univ. Hospital, Korea)
Speakers
The Role of Faslodex in Advanced Breast Cancer Management Pursuing Long Term Treatment Strategy
Prof.Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom)

Plenary Lecture 2 : What is the Current Concept of Molecular Portraits of Human Breast Tumors
Date & Time Apr 20 (Thu.), 13:30-14:30 Venue Halla Hall
Moderators
Prof.Min-Hyuk Lee (Soonchunhyang Univ. Hospital Seoul, Korea)
Speakers
What is the Current Concept of Molecular Portraits of Human Breast Tumors
Prof.Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.)



Symposium 1 : Breast Cancer Prevention and Screening
Date & Time Apr 20 (Thu.), 14:40-15:50 Venue Halla Hall
Moderators
Speakers

Panel Discussion 1 : Elderly Breast Cancer
Date & Time Apr 20 (Thu.), 14:40-15:50 Venue Lotus Hall
Moderators
Speakers

Oral Presentation 1 :
Date & Time Apr 20 (Thu.), 14:40-15:50 Venue Weolla Room
Moderators
Prof.Jeong Soo Kim (The Catholic Univ. of Korea, Uijeongbu St. Mary's Hospital, Korea)
Prof.Woo-Chan Park (The Catholic Univ. of Korea, Yeouido St. Mary's Hospital, Korea)
Speakers
POTENTIAL APPLICATION OF GUGGULSTERONE AS A NOVEL ANTAGONIST OF CXCR4 EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER
Dr.Gautam Sethi (National Univ. of Singapore, Singapore)
A RADIOSENSITIVITY GENE SIGNATURE AND PD-L1 STATUS PREDICT CLINICAL OUTCOME OF PATIENTS WITH INVASIVE BREAST CARCINOMA IN THE CANCER GENOME ATLAS (TCGA) DATASET
Dr.Bum-Sup Jang (Seoul National Univ. Hospital, Korea)


INTERPLAY BETWEEN MEVALONATE AND HIPPO PATHWAYS REGULATES DDX20 VIA YAP IN INVASIVE BREAST CANCERS
Dr.Chao Wang (National Univ. of Singapore, Singapore)


CO-EXISTENCE OF DUCTAL CARCINOMA WITHIN PHYLLODES TUMOR - A REVIEW OF 557 PHYLLODES TUMORS FROM A TWENTY-YEAR REGION-WIDE DATABASE IN HONG KONG AND SHENZHEN, CHINA
Dr.Michael Co (The Univ. of Hong Kong, Hong Kong)


RANDOMIZED PHASE III TRIAL OF IRINOTECAN COMBINED WITH CAPECITABINE VERSUS CAPECITABINE IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) PREVIOUSLY TREATED WITH ANTHRACYCLINE AND TAXANES PROCEED TRIAL
Prof.In Hae Park (National Cancer Center, Korea)


DETECTION OF SPLICEOMIC SIGNATURES FOR PREDICTING ENDOCRINE RESISTANCE IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
Prof.Han-Byoel Lee (Seoul National Univ. Hospital, Korea)


INHERITED MUTATIONS IN BRCA1 AND BRCA2 IN AN UNSELECTED MULTI-ETHNIC COHORT OF ASIAN BREAST CANCER PATIENTS AND HEALTHY CONTROLS FROM MALAYSIA
Dr.Min Min Tan (Cancer Research Malaysia, Malaysia)


CLINICAL APPLICATION OF MULTIGENE PANEL TESTING AND GENETIC COUSELING FOR HEREDITARY/FAMILIAL BREAST CANCER RISK ASSESSMENT: PROSPECTIVE SINGLE CENTER STUDY
Dr.Eun-Shin Lee (Seoul National Univ. College of Medicine, Korea)



Education Session 1 : New Issues in Cancer Research and Treatment
Date & Time Apr 20 (Thu.), 16:00-17:10 Venue Halla Hall
Moderators
Speakers
Clinical Utility of Liquid Biopsy in Cancer
Prof.Byung-Joo Chae (The Catholic Univ. of Korea,, Korea)


Actionable Genome Analysis for Human Cancer
Prof.Woong-Yang Park (Samsung Medical Center, Korea)


New Issues in Cancer Genomics for the Research and Treatment
Prof.Tae-Min Kim (College of Medicine, The Catholic Univ. of Korea, Korea)



Panel Discussion 2 : Special Issues in Stage IV Breast Cancer
Date & Time Apr 20 (Thu.), 16:00-17:10 Venue Lotus Hall
Moderators
Speakers
Surgery for Stage IV Breast Cancer: No Benefit at All?
Prof.Jin Zhang (Tianjin Medical Univ. Cancer Center, China)


New Therapeutic Strategy for CNS Metastases in Breast Cancer
Prof.Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)


How Long Should We Treat Patients with Metastatic Breast Cancer? Is Cure Possible?
Prof.Louis Chow (Macau Univ. of Science and Technology, Hong Kong)



Scientific Program Download